Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on May 19, 2025
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2025 Financial Results
GlobeNewswire
·
May 19, 2025
CARLSBAD, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced it will …
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 19, 2025
WELLESLEY HILLS, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that the Company has granted an inducement …
Global Hemostasis Testing Systems Market: A Rapidly Advancing Frontier in Diagnostic Technology | FMI
EIN Presswire
·
May 19, 2025
Hemostasis Testing Systems Market projected to grow significantly from 2025 to 2035, driven by rising demand for advanced diagnostics. NEWARK, DE, UNITED STATES, May 19, 2025 /EINPresswire.com/ -- The global market for hemostasis testing systems is …
Riding the Digital Wave: Healthcare IT Outsourcing Market Set for Robust Growth from 2025 to 2035
EIN Presswire
·
May 19, 2025
Explore key trends, drivers, and growth forecasts shaping the global healthcare IT outsourcing market from 2025 to 2035 NEWARK, DE, UNITED STATES, May 19, 2025 /EINPresswire.com/ -- The global healthcare sector stands at the crossroads of innovation and …
CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies
GlobeNewswire
·
May 19, 2025
-Collaboration brings together complementary capabilities to co-develop and co-commercialize SRSD107, a next generation, long-acting Factor XI (FXI) small interfering RNA (siRNA) for the treatment of thromboembolic disorders- -SRSD107 demonstrated peak …
Zymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society International Conference
GlobeNewswire
·
May 19, 2025
Company’s first development candidate in autoimmune and inflammatory disease (AIID) demonstrates potent blockade of IL-4, IL-13, and IL-33 signaling pathways critical in respiratory inflammation Novel bispecific design shows promising potential …
Assertio to Participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025
GlobeNewswire
·
May 19, 2025
LAKE FOREST, Ill., May 19, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that Brendan O’Grady, Chief Executive Officer, will present at the virtual Alliance Global Partners Healthcare Company …
Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions
GlobeNewswire
·
May 19, 2025
Timothy Kieffer, Ph.D., appointed Chief Scientific Officer Danny Villeneuve appointed Chief Commercial Officer Terrie Kellmeyer, Ph.D., appointed Senior Vice President, Regulatory Affairs Christian Zapf, J.D., appointed General Counsel SAN DIEGO, May 19, …
Tourmaline Bio to Present Topline Results from the Ongoing Phase 2 TRANQUILITY Trial of Pacibekitug on May 20, 2025
GlobeNewswire
·
May 19, 2025
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune and …
Humacyte to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq
GlobeNewswire
·
May 19, 2025
DURHAM, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that Laura Niklason, M.D., …
AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025
GlobeNewswire
·
May 19, 2025
IRVINE, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, …
Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting
GlobeNewswire
·
May 19, 2025
First Oral Presentation of the Tanruprubart Real-World Evidence (RWE) Study by International Guillain-Barré Syndrome Outcomes Study (IGOS) Researchers Highlights Benefits over Current Standard of Care in Matched Patient Populations Poster Presentations on …
Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 19, 2025
- Interim Jan-2025 results from three trials of Alpha DaRT® in treating pancreatic cancer shared at prestigious 2025 ASCO GI Symposium and R…
Collegium to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 19, 2025
STOUGHTON, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: Mizuho Neuro …
Global Graft Versus Host Disease (GvHD) Treatment Market Projected to Reach USD 5,585.2 Million by 2035 | FMI
EIN Presswire
·
May 19, 2025
GvHD Treatment Market set for robust expansion from 2025 to 2035, driven by novel therapies, R…
Global Equine Veterinary Therapeutics Market Set to Surpass USD 3,047.6 Million by 2035 witness CAGR of 6.8% | FMI
EIN Presswire
·
May 19, 2025
Forecasting growth trends and innovation drivers in the equine veterinary therapeutics market from 2025 to 2035 NEWARK, DE, UNITED STATES, May 19, 2025 /EINPresswire.com/ -- The global equine veterinary therapeutics market is galloping towards …
Sutter Health Awarded Proposition 1 Funding to Expand Behavioral Health Services Across Northern California
GlobeNewswire
·
May 19, 2025
Northern California, May 19, 2025 (GLOBE NEWSWIRE) -- Building upon its commitment to expanding access to timely, high-quality mental health care, not-for-profit Sutter Health today announced it has been awarded $23 million through California’s Proposition …
Creative Diagnostics Provides High-quality ResDetFast™ Residual Nucleic Acid Extraction Kits for Research Applications
EIN Presswire
·
May 19, 2025
NEW YORK, NY, UNITED STATES, May 19, 2025 /EINPresswire.com/ -- In the rapidly evolving field of molecular diagnostics, efficient and reliable nucleic acid extraction remains an important step for downstream applications. As an expert specializing in …
Biopharma's New Power Couple: Creative Biolabs Debuts Functional mRNA Platform at 23rd BioPharma Conference
EIN Presswire
·
May 19, 2025
Creative Biolabs launches a trio of mRNA-centric innovations poised to slash drug development timelines at the 23rd BioPharma Conference (Booth #13, May 7–8). SHIRLEY, NY, UNITED STATES, May 19, 2025 /EINPresswire.com/ -- The platform, designed to …
Medical Electrodes Market CAGR 6.27 % with Growth USD 2632.35 Billion by 2033
EIN Presswire
·
May 19, 2025
Medical Electrodes market size in 2025 is estimated to be 1618.3 million, with projections to grow to 2632.35 million by 2033 at a CAGR of 6.27%. PUNE, MAHARASHTRA, INDIA, May 19, 2025 /EINPresswire.com/ -- "Medical Electrodes Market" research report …